124 related articles for article (PubMed ID: 15010886)
1. Expression of VEGF and brain specific angiogenesis inhibitor-1 in glioblastoma: prognostic significance.
Nam DH; Park K; Suh YL; Kim JH
Oncol Rep; 2004 Apr; 11(4):863-9. PubMed ID: 15010886
[TBL] [Abstract][Full Text] [Related]
2. Experimental anti-angiogenesis causes upregulation of genes associated with poor survival in glioblastoma.
Saidi A; Javerzat S; Bellahcène A; De Vos J; Bello L; Castronovo V; Deprez M; Loiseau H; Bikfalvi A; Hagedorn M
Int J Cancer; 2008 May; 122(10):2187-98. PubMed ID: 18092325
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis and expression of PDGF-C, VEGF, CD105 and HIF-1α in human glioblastoma.
Clara CA; Marie SK; de Almeida JR; Wakamatsu A; Oba-Shinjo SM; Uno M; Neville M; Rosemberg S
Neuropathology; 2014 Aug; 34(4):343-52. PubMed ID: 24612214
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor (VEGF) in astrocytic gliomas--a prognostic factor?
Oehring RD; Miletic M; Valter MM; Pietsch T; Neumann J; Fimmers R; Schlegel U
J Neurooncol; 1999; 45(2):117-25. PubMed ID: 10778727
[TBL] [Abstract][Full Text] [Related]
5. Brain angiogenesis inhibitor 1 is differentially expressed in normal brain and glioblastoma independently of p53 expression.
Kaur B; Brat DJ; Calkins CC; Van Meir EG
Am J Pathol; 2003 Jan; 162(1):19-27. PubMed ID: 12507886
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: correlation with angiogenesis and prognostic significance.
Hara A; Okayasu I
Acta Neuropathol; 2004 Jul; 108(1):43-8. PubMed ID: 15088099
[TBL] [Abstract][Full Text] [Related]
7. Angiogenic molecule expression is downregulated in effusions from breast cancer patients.
Konstantinovsky S; Nielsen S; Vyberg M; Kvalheim G; Nesland JM; Reich R; Davidson B
Breast Cancer Res Treat; 2005 Nov; 94(1):71-80. PubMed ID: 16142438
[TBL] [Abstract][Full Text] [Related]
8. Inducible cyclooxygenase (COX-2) in glioblastoma--clinical and immunohistochemical (COX-2-VEGF) correlations.
Buccoliero AM; Caldarella A; Gheri CF; Taddei A; Paglierani M; Pepi M; Mennonna P; Taddei GL
Clin Neuropathol; 2006; 25(2):59-66. PubMed ID: 16550738
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms.
Plate KH; Breier G; Weich HA; Mennel HD; Risau W
Int J Cancer; 1994 Nov; 59(4):520-9. PubMed ID: 7525492
[TBL] [Abstract][Full Text] [Related]
10. Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema.
Nassehi D
Dan Med J; 2013 Apr; 60(4):B4626. PubMed ID: 23651727
[TBL] [Abstract][Full Text] [Related]
11. Aberrant p53 expression correlates with expression of vascular endothelial growth factor mRNA and interleukin-8 mRNA and neoangiogenesis in non-small-cell lung cancer.
Yuan A; Yu CJ; Luh KT; Kuo SH; Lee YC; Yang PC
J Clin Oncol; 2002 Feb; 20(4):900-10. PubMed ID: 11844810
[TBL] [Abstract][Full Text] [Related]
12. Expression of VEGF and its receptors in different brain tumors.
Huang H; Held-Feindt J; Buhl R; Mehdorn HM; Mentlein R
Neurol Res; 2005 Jun; 27(4):371-7. PubMed ID: 15949234
[TBL] [Abstract][Full Text] [Related]
13. Correlation between chromosome 1p/19q status and VEGF mRNA expression in gliomas.
Yang B; Hao XQ; Zeng XW; Ji TL; Pan S; Feng YG
Genet Mol Res; 2016 Jan; 15(1):. PubMed ID: 26909925
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of vascular endothelial growth factor A, its receptors VEGFR-1, -2, and -3 and co-receptors neuropilin-1 and -2 does not predict bevacizumab response in human astrocytomas.
Baumgarten P; Blank AE; Franz K; Hattingen E; Dunst M; Zeiner P; Hoffmann K; Bähr O; Mäder L; Goeppert B; Machein M; Seifert V; Steinbach JP; Plate KH; Harter PN; Mittelbronn M
Neuro Oncol; 2016 Feb; 18(2):173-83. PubMed ID: 26627848
[TBL] [Abstract][Full Text] [Related]
15. Angiogenic factors in the cerebrospinal fluid of patients with astrocytic brain tumors.
Peles E; Lidar Z; Simon AJ; Grossman R; Nass D; Ram Z
Neurosurgery; 2004 Sep; 55(3):562-7; discussion 567-8. PubMed ID: 15335423
[TBL] [Abstract][Full Text] [Related]
16. Macrophage migration inhibitory factor (MIF) expression in human glioblastomas correlates with vascular endothelial growth factor (VEGF) expression.
Munaut C; Boniver J; Foidart JM; Deprez M
Neuropathol Appl Neurobiol; 2002 Dec; 28(6):452-60. PubMed ID: 12445161
[TBL] [Abstract][Full Text] [Related]
17. Stratification according to recursive partitioning analysis predicts outcome in newly diagnosed glioblastomas.
Yang F; Yang P; Zhang C; Wang Y; Zhang W; Hu H; Wang Z; Qiu X; Jiang T
Oncotarget; 2017 Jun; 8(26):42974-42982. PubMed ID: 28496000
[TBL] [Abstract][Full Text] [Related]
18. Expression of the angiogenic factor thymidine phosphorylase in human astrocytic tumors.
Takano S; Tsuboi K; Matsumura A; Tomono Y; Mitsui Y; Nose T
J Cancer Res Clin Oncol; 2000 Mar; 126(3):145-52. PubMed ID: 10741908
[TBL] [Abstract][Full Text] [Related]
19. Necrogenesis and Fas/APO-1 (CD95) expression in primary (de novo) and secondary glioblastomas.
Tohma Y; Gratas C; Van Meir EG; Desbaillets I; Tenan M; Tachibana O; Kleihues P; Ohgaki H
J Neuropathol Exp Neurol; 1998 Mar; 57(3):239-45. PubMed ID: 9600216
[TBL] [Abstract][Full Text] [Related]
20. 18F-FET microPET and microMRI for anti-VEGF and anti-PlGF response assessment in an orthotopic murine model of human glioblastoma.
Nedergaard MK; Michaelsen SR; Urup T; Broholm H; El Ali H; Poulsen HS; Stockhausen MT; Kjaer A; Lassen U
PLoS One; 2015; 10(2):e0115315. PubMed ID: 25680186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
